Overview

Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M)

Status:
Completed
Trial end date:
2020-08-31
Target enrollment:
Participant gender:
Summary
This study evaluates the investigational drug PledOx in the prevention of chronic chemotherapy induced peripheral neuropathy (CIPN) induced by the drug oxaliplatin.
Phase:
Phase 3
Details
Lead Sponsor:
Egetis Therapeutics
PledPharma AB
Collaborator:
Solasia Pharma K.K.
Treatments:
Edetic Acid
Oxaliplatin
Pyridoxal Phosphate